Skip Ribbon Commands
Skip to main content
Navigate Up
EnglishFrancais
Current Year Centre for Addiction
and Mental Health

Canada needs national plan to combat opioid epidemic

TORONTO, November 7, 2016 - Canada, the second highest consumer of opioids worldwide, must take a comprehensive approach to curb rampant prescribing of opioids and reduce deaths, argue addiction and mental health experts in an analysis in CMAJ (Canadian Medical Association Journal)

“It is late — but not too late — to move toward reducing the toll of opioid overuse and abuse in Canada,” writes Dr. Benedikt Fischer, Centre for Addiction and Mental Health  and the Faculty of Medicine, University of Toronto, Toronto, Ontario, with coauthors.

The use of prescription opioids in Canada has increased steadily over the past 20 years, with correspondingly skyrocketing numbers of misuse, disorders and deaths. Although prescription opioid misuse in adult and adolescent populations has subsided somewhat from previous peaks, the demand for prescription opioid-related addiction treatment has increased substantially. Most worrisome, in 2015, an estimated 2000 Canadians died from opioid overdoses, and many provinces are "on track” for a record number of deaths in 2016.

To curb the use, and related harms, of these potent drugs, the authors propose several interventions, including:

  • developing and enforcing guidelines for prescribing opioids only in exceptional cases where supported by good evidence

  • prescribing only limited dosages and for limited duration as supported by evidence

  • establishing real-time electronic prescription monitoring systems across Canada that physicians and pharmacists must consult before prescribing or dispensing opioids

  • developing a national surveillance system for opioid-related harm indicators, such as emergency department visits and overdose deaths

  • creating availability of and access to evidence-based treatment of opioid addiction.

“These measures surely will not solve the fundamental causes of the prescription opioid problem, but will reduce some of its acute and long-term consequences, including extensive morbidity … and overdose deaths,” the authors conclude.

In a related commentary Drs. M. Eugenia Socias and Keith Ahamad, researchers at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, say that “changing prescribing practices may help protect patients in the future. However, we’re in the middle of an opioid overdose epidemic due to untreated addiction. Major barriers exist across Canada to access medications that can save lives, like buprenorphine/naloxone, which can be provided in primary care settings.”

To combat its opioid epidemic, the United States has introduced the National Pain Strategy, national guidelines for safer prescribing, recognition of addiction medicine as an official medical subspecialty and efforts to expand access to overdose treatment.

The commentary authors call for a national strategy in Canada that will address overprescribing of opioids and open the doors to better treatment for addiction, especially through primary care providers.

Analysis: http://www.cmaj.ca/lookup/doi/10.1503/cmaj.160356
Commentary: http://www.cmaj.ca/lookup/doi/10.1503/cmaj.160554

Media contact for analysis: Sean O’Malley, Media Relations, Centre for Addiction and Mental Health, tel: 416-595-6015, media@camh.ca

Media contact for commentary: Diane Pepin, BC Centre for Excellence in HIV/AIDS, tel: 604-682-2344 x63314,  dpepin@cfenet.ubc.ca

-30-

General media contact: Kim Barnhardt, Communications, CMAJ, kim.barnhardt@cmaj.ca 

Dr. Benedikt Fischer
CAMH Switchboard 416-535-8501
CAMH General Information Toronto: 416-595-6111 Toll Free: 1-800-463-6273
Connex Ontario Help Lines
Queen St.
1001 Queen St. W
Toronto, ON
M6J 1H4
Russell St.
33 Russell St.
Toronto, ON
M5S 2S1
College St.
250 College St.
Toronto, ON
M5T 1R8
Ten offices across Ontario